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Objectives. We used intravascular ultrasound (IVUS) imaging 
to evaluate the chronic vessel responses to Palmaz-Sehatz stents. 
Background. Palmaz-Schatz stents have been shown to inhibit 
early elastic recoil and late arterial remodeling while triggering 
neointimal hyperplasia. However, changes occurring in native 
vessels surrounding stent struts have not been well studied. 
Methods. Postintervention and follow-up (mean [-+SD] 5.4 -+ 
3.8 months) serial IVUS imaging was performed in 25 stents 
without restenosis and 24 with in-stent restenosis. Intravascular 
ultrasound imaging using automatic transducer pullback at 
0.5 mm/s allowed measurement at 1-mm axial increments of 
external elastic membrane (EEM), stent and lumen cross- 
sectional areas (CSAs) and calculation of peristent plaque plus 
media (P+M = EEM - stent) CSA, intrastent plaque (stent - 
lumen) CSA, arterial remodeling (AEEM CSA), tissue growth 
outside the stent (AP+M CSA) and tissue growth within the stent 
(Astent - lumen CSA). Volumes were calculated using the 
Simpson rule. 
Results. Mean EEM CSA increased significantly from 16.9 -4- 
5.0 mm z after intervention to 18.4 + 4.9 mm 2 at follow-up (p < 
0.0001), reflecting an increase in P+M CSA surrounding the stent 
(1.6 _+ 1.3 mmZ). Greater tissue growth within the stent (2.4 -_+ 
2.2 mm 2) correlated weakly, but directly with tissue growth 
surrounding the stent (r = 0.356, p = 0.0121). The ratio of 
peristent/intrastent tissue growth correlated weakly with arterial 
remodeling (r = 0.282, p = 0.0525). Resteuotic stents had more 
tissue growth both within and surrounding the stent than did 
nonrestenotic stents. Volumetric measurements, which could be 
obtained in 15 lesions, showed similar results. 
Conclusions. After implantation there is a chronic increase in 
plaque mass both within and surrounding the stents. The increase 
in peristent plaque mass is associated with adaptive remodeling. 
(J Am Coil Cardiol 1996;28:1134-9) 
Intravascular ultrasound (IVUS) permits detailed, high qual- 
ity, cross-sectional imaging of the coronary, arteries in vivo. The 
normal coronary artery morphology (intima, media and adven- 
titia), the major components of the atherosclerotic plaque 
(lipid, fibrous connective tissue and calcium), the intensely 
echoreflective (but relatively radiolucent) stainless-steel stent 
struts and the changes that occur in the atherosclerotic disease 
process, during transcatheter therapy, and in follow-up can be 
studied in vivo in a manner previously not possible using any 
other imaging modality. 
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Recent IVUS studies have indicated that late lumen loss 
after interventional procedures in nonstented lesions is deter- 
mined primarily by the direction and magnitude of arterial 
remodeling (1), not by cellular proliferation as was originally 
thought (2,3). An increase in arterial cross-sectional rea 
(CSA) is adaptive; analogous to adaptive remodeling in early 
atherosclerosis, adaptive remodeling after catheter-based in-
terventions results in a decreased incidence of restenosis 
despite an increase in plaque mass. In contrast, a decrease in 
arterial CSA leads to lumen compromise and restenosis. 
In two randomized clinical trials Palmaz-Schatz tubular- 
slotted, stainless-steel stents reduced the rate of restenosis 
compared with balloon angioplasty (4,5), presumably by inhib- 
iting acute elastic recoil and chronic pathologic arterial remod- 
eling (6,7). Serial IVUS studies have shown 1) that tubular- 
slotted stents do not recoil over time; 2) that there is a 
stent-related increase in neointimal hyperplasia; and 3) that 
late lumen loss in stented lesions is almost completely the 
result of in-stent neointimal hyperplasia (8,9). However, it is 
not known whether tissue proliferation within the stents is 
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Abbreviations and Acronyms 
CSA cross-sectional area 
EEM external elastic membrane 
1VUS= intravascular ultrasound 
P+M plaque plus media 
associated with tissue proliferation surrounding the stents, and 
whether stents inhibit adaptive as well as pathologic remodel- 
ing. 
The aim of this study was to assess the peristent chronic 
arterial responses to determine 1) whether tissue proliferation 
also occurs in native coronary arteries urrounding Palmaz- 
Schatz stent~, and 2) whether tissue proliferation surrounding 
the stents is associated with adaptive arterial remodeling ofthe 
native vessel wall. 
Methods  
Patients and lesions. This study required adequate visual- 
ization of the deeper arterial structures surrounding the struts 
of the tubular-slotted, stainless-steel Palmaz-Schatz stents 
(Johnson & Johnson Interventional Systems). Although metal 
causes acoustic shadowing, Palmaz-Schatz stents cover only 
10% to 15% of the endovascular surface; thus, there is 
adequate visualization of the deep wall structures in some but 
not all lesions. However, this is inconsistent and unpredictable; 
as a result, it was necessary to screen both postintervention and 
follow-up IVUS images in 81 stents from 61 lesions to identify, 
a cohort with adequate visualization of the media-adventitia 
border for serial analysis. A study that was adequate for 
analysis had visualization of at least 80% of the circumference 
of the external elastic membrane (EEM) CSA over at least a 
4-mm length of the stented segment in both the postinterven- 
tion and follow-up studies. 
We were able to analyze postintervention a d follow-up 
IVUS studies in 49 stents from 39 native vessel esions in 35 
patients (29 men and 6 women, age 63 _+ 11 years). At the time 
of stent implantation, 34% of the patients had a history of 
myocardial infarction, 17% presented with unstable angina nd 
60% presented with stable or progressive angina. At the time 
of follow-up, 9% of the patients had experienced a myocardial 
infarction, 14% presented with unstable angina and 57% 
presented with stable angina. 
Twenty-nine lesions were treated with a single stent and 10 
lesions were treated with two stents; three stents were articu- 
lated "biliary" stents (PS204), and 46 were coronary stents. Of 
the coronary stents, 20 were 3.0 ram, 20 were 3.5 mm and 6 
were 4.0 mm in diameter. Stent location was the left anterior 
descending coronary artery in 15, the left circumflex artery in 
8 and the right coronary artery in 26. The poststent implanta- 
tion adjunct balloon size was 3.5 + 0.4 ram, and the poststent 
implantation adjunct balloon inflation pressure was 16 _+ 
4 arm. 
Intravascular ultrasound imaging protocol. The studies 
were performed using one of two commercially available 
systems. The first system (CVIS/InterTherapy Inc.) incorpo- 
rated a single-element, 25-MHz transducer and an angled 
mirror mounted on the tip of a flexible shaft, which was rotated 
at 1,800 rpm within a 3.9F short monorail polyethylene imag- 
ing sheath to form planar cross-sectional images in real time. 
The second system (Cardiovascular Imaging Systems, Inc.) 
used a 30-MHz, single-element, beveled transducer mounted 
on the end of a flexible shaft and rotated at 1,800 rpm within 
either a 2.9F long monorail/common distal lumen imaging 
sheath or a 3.2F short monorail imaging sheath. With both 
systems, the transducer was withdrawn within the stationary 
imaging sheath at a speed of 0.5 mm/s using a motorized 
transducer pullback device. Motorized transducer pullback 
through a stationary imaging sheath permitted the transducer 
to move at the same speed as the proximal end of the catheter 
and facilitated comparative measurements on serial studies; 
this has been validated in vivo (10). 
All IVUS studies were performed after administration f 
0.2 mg of intracoronary nitroglycerin. To perform the imaging 
sequence the transducer was positioned approximately 10 mm 
beyond the distal edge of the stent and the motorized trans- 
ducer pullback device was activated, and imaging continued 
until the transducer reached the aorto-ostial junction. Studies 
were recorded onto high resolution s-VHS videotape for 
off-line analysis. Patients were studied only after giving written, 
informed consent; all IVUS studies have the ongoing approval 
of the Washington Hospital Institutional Review Board. 
Quantitative 1VUS analysis. Using the motorized trans- 
ducer pullback device, each stent was divided into 1-mm long 
axial segments. At a pullback speed of 0.5 ram/s, 1 mm of axial 
stent length equaled 2 s of videotape. In 15 of the stents, the 
EEM, stent and lumen CSAs could be measured in all image 
slices. In the remaining 34 stents, the EEM, stent and lumen 
CSAs could be measured in a variable number of contiguous 
images lices over at least a 4 mm of axial stent length. 
Validation of cross-sectional measurements of EEM, stent, 
lumen and plaque plus media (P+M) CSAs by IVUS has been 
previously reported (11-15). The term external elastic mem- 
brane corresponds to the media-adventitia border, which is a 
reproducible measurement of the total arterial CSA. Because 
media thickness could not be measured accurately, P+M CSA 
was used as a measurement of the amount of atherosclerotic 
plaque. When the tissue encompassed the catheter, the lumen 
was assumed to be the size of the imaging catheter. 
Using computerized planimetry, each border (EEM, stent 
and lumen) was routinely traced two to four times (Fig. 1). The 
following calculations were then made for each image slice. 
Finally, the results for each stent were averaged: 1) arterial 
remodeling (ram 2) -- A (after intervention tofollow-up) EEM 
CSA; 2) chronic stent recoil (ram 2) = A (after intervention to
follow-up) stent CSA; 3) in-stent plaque CSA (ram 2) = stent 
CSA - lumen CSA; 4) peristent P+M CSA (mm 2) = EEM 
CSA stent CSA; 5) in-stent tissue growth (mm 2) = A (after 
intervention to follow-up) intrastent plaque CSA; 6) peristent 
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Table 1. Planar Intravascular Ultrasound Measurements of External 
Elastic Membrane, Stent and Lumen Cross-Sectional Areas After 
Intervention and at Follow-Up for All 49 Lesions 
After p 
Intervention Follow-Up Value 
Mean EEM CSA (mm 2) 16.9 _+ 5.0 18.4 _+ 4.9 < 0.0001 
Mean stent CSA (mm 2) 8.2 _+ 2.4 8.2 ± 2.2 0.2127 
Mean lumen CSA (mm 2) 8.2 _+ 2.2 5.6 _+ 2.2 < 0.0001 
Mean intrastent plaque CSA (mm 2) 0.0 + 0.1 2.4 _+ 2.2 < 0.0001 
Mean peristent plaque CSA (mm 2) 8.7 + 3.3 10.4 _+ 3.3 < 0.0001 
Data presented are mean value + SD. CSA = cross-sectional area; EEM = 
external e astic membrane. 
Figure 1. Planar intravascular ultrasound images of a Palmaz-Schatz 
stent after intervention and at follow-up are shown. Each is duplicated, 
and the duplicate is labeled. After intervention, the EEM CSA 
measured 17.9 mm 2, the stent CSA measured 8.4 mm 2, and the 
peristent P+M (EEM - stent) CSA measured 9.5 mm 2. At follow-up, 
the EEM CSA increased to 22.5 mm 2 (a 26% increase), the stent CSA 
did not change, and the lumen CSA decreased to 4.1 mm 2. Thus, there 
was 4.3 mm 2 of in-stent neointimal tissue proliferation (stent - lumen 
CSA) and an increase of 4.6 mm 2 (48%) in peristent P+M CSA. 
tissue growth (mm 2) = ~ (after intervention to follow-up) 
peristent P+M CSA; and 7) total tissue growth (mm 2) = 
in-stent tissue growth + peristent issue growth. Arterial re- 
modeling was defined as adaptive (increase in EEM CSA) or 
pathologic (decrease in EEM CSA). 
In the 15 stents with complete visualization of the EEM 
CSA, a similar serial analysis of the EEM, stent and lumen 
volumes was also performed. External elastic membrane, stent, 
lumen and plaque volumes (both within and surrounding the 
stent) were calculated using the Simpson rule. These methods 
have been reported previously (16,17). 
The minimal lumen CSA within each stent was compared 
with the reference segment. The reference segment was defined 
as the most normal-looking cross section within 5 mm proximal 
and distal to the stented lesion, but before any major side 
branch. If a stent was placed in an ostial location, only a distal 
reference segment was measured, Restenosis was defined as 
->75% area stenosis when the minimal umen CSA within the 
stent was compared with the reference lumen CSA (average of 
the proximal and distal reference lumen CSAs). 
Reproducibility of IVUS measurements. The reproducibil- 
ity of stent, lumen and EEM CSAs in our laboratory has been 
reported previously (1,18). However, because of the difficulty 
in visualizing the EEM through the stent struts, the reproduc- 
ibility of the measurement was assessed specifically for the 
current study. In both postintervention a d follow-up studies, 
the EEM CSA was measured twice in 10 stents. Repeated 
measurements were performed at least 2 months apart. 
Statistics. Statistical analysis was performed using Stat- 
View 4.02 (Abacus Concepts). Quantitative data were pre- 
sented as mean value ± SD. Comparisons between groups 
were performed using paired and unpaired t tests for contin- 
uous variables or factorial analysis of variance (with post hoc 
analysis using the Fisher protected least significant difference), 
as appropriate. The level of significance was p -< 0.05. 
Resu l ts  
Cross-sectional area measurements (Table 1). The postin- 
tervention reference lumen CSA measured 9.4 ± 3.7 mm 2. 
Postintervention and follow-up EEM, stent and lumen 
CSAs could be evaluated in a total of 589 stent image slices 
within the 49 stents for a mean of 12 image slices per stent. 
Overall, the mean stent CSA did not change (8.2 ± 2.4 to 8.2 _+ 
2.2 mm 2, p = NS). The mean lumen CSA decreased from 
8.2 ± 2.2 mm 2 after intervention to 5.6 ± 2.8 mm 2 at follow-up, 
entirely as a result of an increase in tissue within the stent. 
Similarly, the mean EEM CSA increased significantly from 
16.9 ± 5.0 mm 2 after intervention to 18.4 ± 4.9 mm 2 at 
follow-up, as a result of a mean increase in P+M CSA 
surrounding the stent (from 8.7 ± 3.3 to 10.4 ± 3.3 mm 2, Fig. 
1). The results are also shown in Figure 2. 
Total mean tissue growth measured 4.1 _+ 2.8 mm 2. Mean 
tissue growth within the stent was greater than mean tissue 
growth surrounding the stent (2.4 ± 2.2 vs. 1.6 ± 1.3 mm 2, p = 
0.0015). The two were weakly but directly correlated (r = 
0.356, p = 0.0121). 
Arterial remodeling (A mean EEM CSA) correlated 
strongly with mean peristent issue growth (r = 0.938, p < 
0.0001) and moderately with mean total tissue growth (r = 
0.628, p < 0.0001), but only weakly with mean in-stent issue 
growth (r -- 0.278, p = 0.0528). 
Neither mean total tissue growth, mean peristent issue 
growth, mean in-stent tissue growth, nor the ratio of mean 
in-stent/mean peristent issue growth correlated with mean 
postintervention EEM, stent, lumen or peristent P+M CSAs. 
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Figure 2. Planar IVUS results of the mean (per stent) postinterven- 
tion and follow-up EEM, in-stent plaque and peristent P+M CSAs, in 
the total cohort of 49 stented lesions. 
The ratio of mean peristent/mean i stent tissue growth corre- 
lated weakly with arterial remodeling (r = 0.282, p = 0.0525). 
The mean peristent issue proliferation tended to be inversely 
related to the mean postintervention peristent P+M CSA (r = 
0.220, p = 0.1295). 
There was no predilection for peristent issue proliferation 
and adaptive remodeling to occur preferentially at any partic- 
ular location within the stents (e.g., stent margins vs. stent 
bodies vs. central articulation). 
The image slice with the smallest lumen CSA in each of the 
49 stents was compared with the mean cross-sectional mea- 
surements. There was significantly more lumen loss (3.9 _+ 2.2 
vs. 2.6 _+ 2.2 mm 2, p < 0.0001) and significantly more tissue 
growth within the stent (3.9 +_ 2.2 vs. 2.4 _+ 2.1 mm 2, p < 
0.0001). The late increase in EEM area (1.8 _+ 1.9 vs. 1.5 _+ 
2.0 mm z, p = 0.1162) and the amount of peristent issue 
proliferation (1.8 _+ 1.8 vs. 1.6 _+ 2.0 mm 2, p = 0.3613) were 
similar. 
Restenotic versus nonrestenotic stents. Twenty-four stents 
were restenotic and 25 were nonrestenotic (Table 2). Re- 
stenotic stents tend to be smaller, have more in-stent and 
peristent tissue proliferation and have a greater late increase in 
EEM CSA. 
Volumetric IVUS measurements (Table 3). Volumetric 
analysis was possible in seven restenotic and eight nonre- 
stenotic stents. The postintervention and follow-up measure- 
ments in these 15 stents were similar to the 34 stents in which 
only limited analysis was possible. 
Volumetric analysis paralleled the cross-sectional nalysis. 
Overall, stent volume did not change (126 _+ 36 to 123 _+ 
35 ram3). Lumen volume decreased from 126 _+ 36 mm 3 after 
intervention to 84 _+ 49 mm 3 at follow-up, as a result of an 
increase of 37 _+ 32 mm 3 in tissue volume within the stent. The 
EEM volume increased significantly from 246 _+ 66 mm 3 after 
intervention to 263 _+ 71 mm 3, as a result of an increase in 
tissue surrounding the stent (from 120 _+ 45 to 138 + 45 mm3). 
Table 2. Comparison of Serial Planar Intravascular Ultrasound 
Findings in Restenotic Versus Nonrestenotic Lesions 
Restenosis No Restenosis 
(n - 24) (n = 25) p Value 
Mean postintervention EEM 16.1 + 4.0 17.7 _+ 5.8 0.2476 
CSA (ram 2) 
Mean postintervention lumen 7.6 + 1.8 8.8 + 2.4 0.0581 
CSA (ram z) 
Mean postintervcntion peristent 8.4 ± 2.8 8.9 _+ 3.7 0.6481 
plaque CSA (mm a) 
Mean follow-up lumen CSA 3.6 + 1.9 7.5 + 2.2 < 0.0001 
(mm ~) 
AMean EEM CSA (mm-') 1.9 + 1.6 1.1 _+ 1.3 0.0545 
AMean stent CSA (mm 2) 0.0 + 0.5 0.2 + 0.5 0.3247 
&Mean lumen CSA (ram :) 4.0 + 2.3 1.3 _+ 0.8 < 0.0001 
&Mean intrastent plaque CSA 4.II _+ 2.1 1.2 = 0.7 < 0.0001 
(mm -~) 
AMean peristent plaque CSA 1.9 t 1.4 1.3 + 1.(/ 0.0640 
(ram 2) 
AMean total (intrastent + 5.9 _+ 2.8 2.4 _+ 1.5 < 0.0001 
peristent) plaque CSA (mm:) 
Data presented are mean value _+ SD. Abbreviations as in Table 1. 
Tissue growth within the stent (37 _+ 32 mm 3) was greater than 
tissue growth surrounding the stent (19 _+ 18 mm 3, p -- 
0.0204). 
Reproducibility of EEM measurements. In 10 stented le- 
sions repeated measurement of the EEM CSA was performed 
in 119 image slices after intervention and in 117 image slices at 
follow-up. The difference in repeated measurements of the 
postintervention EEM CSA was 4.0 _+ 2.9%; the difference in 
repeated measurements of the follow-up EEM CSA was 4.3 + 
3.6%. Correlation of repeated measurements for all 236 image 
slices was r = 0.96. 
Discuss ion  
This study shows that endovascular tubular-slotted, 
stainless-steel stents induce tissue proliferation both within the 
endoluminal stent surface and in the tissue layers surrounding 
the metallic Palmaz-Schatz stent struts. Both in-stent and 
peristent issue proliferation is greater in restenotic than in 
nonrestenotic stents. Tissue proliferation surrounding the 
Palmaz-Schatz stents is accompanied by adaptive remodeling 
(increase in EEM CSA). 
Table 3. Intravascular Ultrasound Measurements of External Elastic 
Membrane, Stent and Lumen Volumes After Intervention and at 
Follow-Up for 15 Lesions Suitable for Volumetric Analysis 
After 
Intervention Follow-Up p Value 
EEM volume (mm 3) 246 _+ 66 263 + 71 0.0067 
Stent volume (mm 3) 126 _+ 36 123 + 35 0.9821 
Lumen volume (ram 3) 126 +_ 36 84 _+ 49 0.0013 
Intrastent plaque volume (mm x) 0 _+ 0 37 _+ 32 < 0.0001 
Peristent plaque volume (ram 3) 120 _+ 45 138 + 45 0.0039 
Data presented are mean value + SD. EEM - external elastic membrane. 
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Tissue proliferation after stent placement. Previous stud- 
ies have indicated that intraluminal tissue proliferation within 
tubular-slotted stents is a complex process involving an early 
thrombotic layer, which, over a period of weeks, is replaced by 
fibromuscular cells, extracellular matrix and eventually colla- 
gen (19-21). In animal models, maximal neointimal thickness 
occurs at approximately 8 weeks after stent implantation; this 
is followed by scarring and thinning (19). 
The current IVUS study suggests hat this process may also 
occur in the tissue layers surrounding the stents. As with 
in-stent neointimal tissue proliferation, which has been shown 
to be uniformly distributed over the length of the stent (9), 
there was no predilection for peristent tissue proliferation to 
be located at the ends, bodies or central articulation of the 
Palmaz-Schatz stent. 
There was a direct but weak correlation between the 
increase in plaque mass inside and outside of the stent. There 
are several possible explanations for this weak correlation. 
Neointimal tissue proliferation inside the stent and the in- 
crease in P+M outside the stent may, in part, have different 
mechanisms. In-stent neointimal tissue proliferation may be a 
homogeneous process, whereas the peristent increases in 
plaque mass may represent the net result of smooth muscle cell 
proliferation and either growth or apoptosis of the existing 
atherosclerotic plaque. Early platelet activation or thrombus 
formation, or both, on the inner surface of the stent (which 
may not occur on the outer surface of the stent, where there is 
stent-tissue contact) may lead to preferential endoluminal 
tissue proliferation. There may be variations in smooth muscle 
cell migration, as well as different degrees of smooth muscle 
cell proliferation, inmedia versus neointima. Alternatively, the 
variation in the remodeling responses of the deep wall struc- 
tures may contribute to the relative amounts in-stent versus 
peristent issue accumulation. Greater adaptive remodeling 
(increase in EEM CSA) may facilitate peristent tissue accu- 
mulation, although deep wall structures that are resistant to 
adaptation may force tissue proliferation to be confined to the 
endoluminal surface of the stent. In the current study there was 
a weak correlation between the ratio of peristent/in-stent tissue 
accumulation and the degree of adaptive arterial remodeling. 
Arterial remodeling after stent placement. Stents cause 
several changes in the surrounding media and adventitia. 
Short-term effects of stent placement on the vessel wall include 
thinning of the media and possible rupture of the internal 
elastic membrane (22), whereas long-term include inflamma- 
tory infiltrates urrounding the stent wires, replacement of the 
media by myofibroblastic proliferation and increases in the 
collagen and mucopolysaccharide content of the media (22). 
Although these changes may otherwise lead to pathologic 
remodeling (decrease in external EEM CSA) and restenosis 
(as occurs in nonstented lesions), stents have been shown to 
reduce restenosis, in part, by virtually eliminating pathologic 
arterial remodeling. 
The Serial Ultrasound Analysis of Restenosis (SURE) trial 
has demonstrated that remodeling after nonstent interventions 
is biphasic with early adaptive remodeling (increase in external 
EEM CSA at 1 month) and late pathologic remodeling (de- 
crease in EEM CSA at 6 months) (23). When it is sustained, 
adaptive remodeling has been shown to accommodate n oin- 
timal tissue growth to prevent restenosis n both animal models 
and humans (1,24). This may be analogous to arterial remod- 
eling in the early atherosclerotic disease process, in which 
plaque accumulation is compensated forby an increase of total 
vessel CSA, and lumen compromise is delayed until plaque 
accumulation outstrips the adaptive capacities of the artery 
(25-27). Although stents prevent late pathologic remodeling, 
the current study shows that stents do not inhibit early adaptive 
arterial remodeling. In some lesions this may represent an 
additional means of accommodating the stent-related neointi- 
mal tissue proliferation. However, whether or not stents limit 
the magnitude of the potential adaptive remodeling responses 
in the instrumented artery cannot be determined from the 
current study. 
Study limitations. This study represented a selected series 
of lesions studied after intervention and at follow-up. There 
may have been a selection bias 1) because of the nature of the 
follow-up, and 2) because less than 50% of the stented lesions 
for which we had serial IVUS studies were adequate for serial 
analysis of the peristent vascular changes. The ability to 
visualize the deep arterial structures through the stent struts 
was unpredictable. Furthermore, because the analysis was 
limited to image slices in which the EEM could be well 
visualized through the stent struts, it was not possible to relate 
peristent arterial responses to the original lesion (either the 
location of the center of the lesion or the underlying plaque 
composition). However, this was intended as a mechanistic 
study, and was not designed to determine the predictors of 
these peristent vascular responses. Finally, whether these 
findings apply to other stents, as well, cannot be determined 
from this study. 
Conclusions. In-stent restenosis the result of endovascu- 
lar neointimal tissue proliferation, accompanied by a lesser 
amount of peristent tissue proliferation. Palmaz-Schatz stents 
prevent pathologic remodeling but not adaptive remodeling. 
Adaptive remodeling surrounding Palmaz-Schatz stents pre- 
sumably occurs in response to peristent tissue proliferation. 
The ultimate effect of these peristent arterial responses is 
unknown. 
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